162 related articles for article (PubMed ID: 26171027)
1. Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer.
Yuan Y; Shen N; Yang SY; Zhao L; Guan YM
Oncol Lett; 2015 Jul; 10(1):342-348. PubMed ID: 26171027
[TBL] [Abstract][Full Text] [Related]
2. [Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis].
Zhou S; Liu C; Wu SM; Wu RL
Ai Zheng; 2005 Jul; 24(7):874-9. PubMed ID: 16004819
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients.
Du ZM; Hu CF; Shao Q; Huang MY; Kou CW; Zhu XF; Zeng YX; Shao JY
Int J Cancer; 2009 Oct; 125(8):1832-41. PubMed ID: 19582878
[TBL] [Abstract][Full Text] [Related]
4. Epithelial expression of extracellular matrix metalloproteinase inducer/CD147 and matrix metalloproteinase-2 in neoplasms and precursor lesions derived from cutaneous squamous cells: An immunohistochemical study.
Ayva SK; Karabulut AA; Akatli AN; Atasoy P; Bozdogan O
Pathol Res Pract; 2013 Oct; 209(10):627-34. PubMed ID: 23948694
[TBL] [Abstract][Full Text] [Related]
5. [Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance].
Gou XX; Jin F; Chen HX; Wu WL; Chen L; Zeng Y
Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1264-7. PubMed ID: 20646600
[TBL] [Abstract][Full Text] [Related]
6. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN
Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143
[TBL] [Abstract][Full Text] [Related]
7. CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas.
Lüke J; Vukoja V; Brandenbusch T; Nassar K; Rohrbach JM; Grisanti S; Lüke M; Tura A
BMC Ophthalmol; 2016 Jun; 16():74. PubMed ID: 27255356
[TBL] [Abstract][Full Text] [Related]
8. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma.
Ishibashi Y; Matsumoto T; Niwa M; Suzuki Y; Omura N; Hanyu N; Nakada K; Yanaga K; Yamada K; Ohkawa K; Kawakami M; Urashima M
Cancer; 2004 Nov; 101(9):1994-2000. PubMed ID: 15372476
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features.
Tian X; Ye C; Yang Y; Guan X; Dong B; Zhao M; Hao C
J Transl Med; 2015 Oct; 13():337. PubMed ID: 26507719
[TBL] [Abstract][Full Text] [Related]
10. Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and its correlation with poor prognosis.
Gou X; Chen H; Jin F; Wu W; Li Y; Long J; Gong X; Luo M; Bi T; Li Z; He Q
Pathol Oncol Res; 2014 Apr; 20(2):475-81. PubMed ID: 24357157
[TBL] [Abstract][Full Text] [Related]
11. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions.
Sun J; Hemler ME
Cancer Res; 2001 Mar; 61(5):2276-81. PubMed ID: 11280798
[TBL] [Abstract][Full Text] [Related]
12. CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
Huang L; Xu AM; Peng Q
Int J Clin Exp Pathol; 2015; 8(2):1929-37. PubMed ID: 25973085
[TBL] [Abstract][Full Text] [Related]
13. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
Zhong WD; Han ZD; He HC; Bi XC; Dai QS; Zhu G; Ye YK; Liang YX; Qin WJ; Zhang Z; Zeng GH; Chen ZN
Oncology; 2008; 75(3-4):230-6. PubMed ID: 18852494
[TBL] [Abstract][Full Text] [Related]
14. [Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer].
Xue S; Li SX; Wu ZS; Wang XN; Wu Q; Yang F
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):524-8. PubMed ID: 20021962
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma.
Piao S; Zhao S; Guo F; Xue J; Yao G; Wei Z; Huang Q; Sun Y; Zhang B
J Cancer Res Clin Oncol; 2012 Apr; 138(4):627-35. PubMed ID: 22215147
[TBL] [Abstract][Full Text] [Related]
17. High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.
Zhao S; Ma W; Zhang M; Tang D; Shi Q; Xu S; Zhang X; Liu Y; Song Y; Liu L; Zhang Q
Med Oncol; 2013 Mar; 30(1):335. PubMed ID: 23263825
[TBL] [Abstract][Full Text] [Related]
18. [Expression of CD147 and matrix metalloproteinase-9 in children with non-Hodgkin's lymphoma and its correlation with prognosis].
Liu AG; Hu Q; Tao HF; Liu SY; Zhang LQ; Hu Y
Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):785-8. PubMed ID: 20021816
[TBL] [Abstract][Full Text] [Related]
19. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer.
Monge M; Colas E; Doll A; Gonzalez M; Gil-Moreno A; Planaguma J; Quiles M; Arbos MA; Garcia A; Castellvi J; Llaurado M; Rigau M; Alazzouzi H; Xercavins J; Alameda F; Reventos J; Abal M
Cancer Res; 2007 Jul; 67(14):6753-9. PubMed ID: 17638886
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma.
Planagumà J; Liljeström M; Alameda F; Bützow R; Virtanen I; Reventós J; Hukkanen M
Hum Pathol; 2011 Jan; 42(1):57-67. PubMed ID: 20970160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
